PDT Partners’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-2,364
| Closed | -$241K | – | 694 |
|
|
2023
Q2 | $241K | Sell |
2,364
-470
| -17% | -$47.9K | 0.03% | 489 |
|
|
2023
Q1 | $501K | Buy |
2,834
+1,797
| +173% | +$318K | 0.07% | 388 |
|
|
2022
Q4 | $401K | Buy |
1,037
+335
| +48% | +$130K | 0.06% | 429 |
|
|
2022
Q3 | $236K | Sell |
702
-426
| -38% | -$143K | 0.04% | 665 |
|
|
2022
Q2 | $371K | Sell |
1,128
-2,025
| -64% | -$666K | 0.03% | 689 |
|
|
2022
Q1 | $1.38M | Buy |
3,153
+108
| +4% | +$47.2K | 0.12% | 269 |
|
|
2021
Q4 | $1.34M | Buy |
3,045
+138
| +5% | +$60.5K | 0.1% | 303 |
|
|
2021
Q3 | $1.62M | Buy |
2,907
+851
| +41% | +$473K | 0.12% | 276 |
|
|
2021
Q2 | $1.06M | Buy |
2,056
+249
| +14% | +$128K | 0.07% | 370 |
|
|
2021
Q1 | $1.41M | Sell |
1,807
-214
| -11% | -$167K | 0.1% | 310 |
|
|
2020
Q4 | $1.1M | Sell |
2,021
-110
| -5% | -$59.9K | 0.07% | 310 |
|
|
2020
Q3 | $976K | Buy |
2,131
+248
| +13% | +$114K | 0.06% | 310 |
|
|
2020
Q2 | $1.16M | Buy |
+1,883
| New | +$1.16M | 0.08% | 260 |
|